Ardent Health, Inc. ARDT
At closeNov 6, 2026, 4:45 PM EST
After hours · Nov 6, 4:45 PM ET
- YTD
- +95.92%
- 1 year
- +19.64%
- Market cap
- 2.44B
- Revenue (ttm)
- 6.45B
- Profit margin
- 2.27%
- EPS (ttm)
- 1.03
- Shares out
- 140.93M
- P/E ratio
- 16.80
- Forward P/E
- 13.59
- YTD return
- +95.92%
- 1-year return
- +19.64%
- Volume
- 3.47M
- Avg volume
- 458.21K
- Open
- 15.84
- Previous close
- 15.90
- Day's range
- 15.58 – 17.68
- 52-week range
- 7.83 – 17.30
- Beta
- 0.58
- Analysts
- Buy
- Price target
- 12.79 (-26.1%)
- Earnings date
- Mar 3, 2027
1D +1.40 (+8.81%)
Key statistics
- Enterprise value
- 4.13B
- PEG ratio
- 0.00
- Price / sales
- 0.38
- Price / book
- 1.75
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 3.10%
- Free cash flow
- 185.77M
- Total cash
- 766.24M
- Total debt
- 2.27B
- Return on equity
- 13.52%
- Short % of float
- 12.16%
- 50-day average
- 11.32
- 200-day average
- 10.07
Analyst view
Consensus: buy
- Target (low)
- 11.00
- Target (mean)
- 12.79
- Target (high)
- 14.00
- Strong buy1
- Buy6
- Hold5
- Sell0
- Strong sell1
Next earnings
Mar 3, 2027
Expected Mar 3, 2027. Consensus EPS estimate 0.34333.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 3, 2027 | Dec 30, 2026 | 0.34 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.232 | 0.31 | +0.08 | +33.62% |
| Aug 4, 2026 | Jun 30, 2026 | 0.1817 | 0.12 | -0.06 | -33.96% |
| May 5, 2026 | Mar 31, 2026 | 0.18 | 0.28 | +0.10 | +55.56% |
| Mar 4, 2026 | Dec 31, 2025 | 0.348 | 0.32 | -0.03 | -8.05% |
| Nov 12, 2025 | Sep 30, 2025 | 0.424 | 0.52 | +0.10 | +22.64% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Stephens & Co. | main | Overweight | Overweight |
| Nov 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Sep 23, 2026 | BMO Capital | init | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | main | Outperform | Outperform |
| Aug 10, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | main | Buy | Buy |
About Ardent Health, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- ardenthealth.com
News
What Ardent Health (ARDT) Said on Its Q3 Earnings Call 
Stephens & Co. Maintains Overweight on Ardent Health, Raises Price Target to $21 - RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18
12 Health Care Stocks Moving In Thursday's Intraday Session 
Ardent Health Partners Q3 2026 Earnings Call Transcript 
Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates - Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est
Ardent Health Partners Q3 EPS $0.31 Beats $0.22 Estimate, Sales $1.624B Beat $1.603B Estimate 
Ardent Health Reports Third Quarter 2026 Results 
BMO Capital Initiates Coverage On Ardent Health with Market Perform Rating, Announces Price Target of $11
Your note
Sign in to keep a note on ARDT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BONICK MARTIN | Chief Executive Officer | Stock Award(Grant) | Mar 31, 2026 | 1,437,940 |
| BYERS DAVID RAYNOR | Officer | Stock Award(Grant) | Mar 31, 2026 | 130,445 |
| BYNOE PETER C B | Director | Stock Award(Grant) | Mar 31, 2026 | 115,367 |
| CASPERS DAVE | Chief Executive Officer | Stock Award(Grant) | Jun 30, 2026 | 174,930 |
| CHERNIN ETHAN | Officer | Stock Award(Grant) | Mar 10, 2026 | 68,396 |
| GOODYEAR WILLIAM M | Director | Stock Award(Grant) | Mar 31, 2026 | 115,367 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Chai Trust Co LLC | 54.77% | 77,246,499 | 1.34B | Jun 29, 2026 |
| Ventas Inc | 6.62% | 9,342,501 | 161.53M | Jun 29, 2026 |
| Blackrock Inc. | 1.54% | 2,176,348 | 37.63M | Jun 29, 2026 |
| Ameriprise Financial, Inc. | 1.50% | 2,110,599 | 36.49M | Jun 29, 2026 |
| Goldentree Asset Management LP | 1.12% | 1,580,423 | 27.33M | Jun 29, 2026 |
| AQR Capital Management, LLC | 1.03% | 1,447,810 | 25.03M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 0.73% | 1,028,221 | 17.78M | Jul 30, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 0.51% | 723,802 | 12.51M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.47% | 661,990 | 11.45M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.46% | 647,758 | 11.20M | Sep 29, 2026 |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 0.39% | 551,293 | 9.53M | Jun 29, 2026 |
| First TRT Exch-Trd AlphaDEX Fd.-First TRT Small Cap Core AlphaDEX Fd. | 0.32% | 457,253 | 7.91M | Sep 29, 2026 |